Clinical Trial Update: Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/Phase 2 clinical trial evaluating fecal microbiota transplantation for Chronic Granulomatous Disease-associated colitis, sponsored by NIAID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease-associated Colitis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Granulomatous Disease-associated Colitis | Phase 1, Phase 2 | Status: RECRUITING